Equities

Rion Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Rion Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,873.00
  • Today's Change-79.00 / -2.68%
  • Shares traded32.30k
  • 1 Year change+9.41%
  • Beta1.0692
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Rion Co Ltd is a Japan-based company mainly engaged in the development, manufacture, sale and service of particle counters, medical equipment and environmental equipment. It operates through three segments. The Particle Counter segment manufactures and sells particle counters such as liquid particle counters and airborne particle counters. The Medical Equipment segment manufactures and sells hearing aids and medical testing equipment. The Environmental Equipment segment manufactures and sells sound and vibration measuring instruments such as sound level meters, vibration meters, seismometers and frequency analyzers.

  • Revenue in JPY (TTM)27.94bn
  • Net income in JPY2.98bn
  • Incorporated1944
  • Employees1.01k
  • Location
    Rion Co Ltd3-20-41, Higashimoto-machiKOKUBUNJI-SHI 185-8533JapanJPN
  • Phone+81 423597830
  • Fax+81 423597447
  • Websitehttps://www.rion.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medius Holdings Co Ltd295.20bn1.36bn18.59bn2.61k13.740.91694.890.06360.8660.8613,250.33911.802.3918.174.56112,928,700.001.101.654.356.0311.8212.070.45960.64920.924313.810.587328.5711.126.5322.307.6516.287.39
Techno Medica Co Ltd10.70bn1.04bn22.50bn244.0017.151.2419.812.10149.78149.781,542.982,077.510.64062.173.6943,841,880.006.226.587.167.7947.6849.669.7112.305.99--0.0040.22-3.680.1936-25.480.0825-40.566.77
Findex Inc5.90bn1.18bn23.63bn311.0019.144.1515.704.0046.3946.39232.45214.020.94678.734.9918,984,330.0019.2116.4821.5419.1963.7758.1820.2916.354.18--0.0034.7312.516.419.7518.41-4.0213.40
Japan Tissue Engineering Co., Ltd.2.26bn-461.45m24.41bn204.00--4.63--10.81-11.36-11.3655.62129.740.36614.015.6311,071,850.00-7.48-4.87-8.33-5.5159.6259.41-20.43-15.896.59--0.00---2.341.23-278.32--0.5717--
Kusurinomadoguchi Inc11.71bn2.59bn29.26bn484.0011.282.929.102.50228.38228.381,033.34882.360.6939--3.1924,186,230.0015.71--26.98--56.02--22.65------0.158--28.41--133.66------
Mizuho Medy Co Ltd11.26bn3.43bn33.85bn187.009.881.819.173.01179.80179.80591.12980.860.52251.552.09--15.9027.7417.9633.0669.4474.5130.4336.696.46-------1.4821.77-9.2262.0723.87--
Rion Co Ltd27.94bn2.98bn35.47bn1.01k11.891.078.151.27241.73241.732,267.252,682.200.71751.673.8927,692,170.007.656.578.727.6249.5350.1110.669.273.55--0.0028.398.365.377.829.9520.048.61
Nippon Care Supply Co., Ltd.34.10bn2.17bn39.38bn1.45k17.402.104.221.15139.36139.362,194.671,155.761.26101.8030.3523,453,350.008.007.3711.529.8036.4536.776.356.340.7615--0.091359.8011.9410.8813.573.7013.338.76
Cyberdyne Inc4.11bn-3.00m41.10bn211.00--1.5965.1310.00-0.0142-0.014219.46188.520.08331.607.7019,469,190.00-0.1034-1.36-0.1056-1.3861.0857.96-1.24-20.8013.94--0.0108--0.68919.5960.91---5.51--
Win-Partners Co Ltd87.25bn2.14bn43.71bn630.0018.891.7318.120.50175.8575.853,098.48830.261.8321.984.45138,488,200.004.494.298.527.9211.9812.402.452.591.62--0.0068.005.644.759.981.5233.839.52
France Bed Holdings Co Ltd61.19bn2.72bn46.35bn1.81k18.621.135.820.757571.6571.651,627.811,177.550.90172.946.0633,769,870.004.014.195.055.6555.0053.374.454.781.951,504.330.244146.932.382.93-6.0014.15-2.507.39
Japan Eyewear Holdings Co Ltd17.99bn4.22bn47.64bn580.0011.432.807.952.65172.64172.64736.69704.930.47411.8016.5631,022,410.0011.13--12.75--79.15--23.48--0.785318.060.4966--23.20--80.15------
Medikit Co Ltd23.68bn3.09bn47.64bn989.0014.150.952410.472.01211.98211.981,621.483,149.960.46433.144.1023,940,550.006.075.706.726.3038.5539.3713.0713.845.33--0.000241.813.222.54-1.820.854821.5712.47
Data as of Feb 13 2026. Currency figures normalised to Rion Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

19.36%Per cent of shares held by top holders
HolderShares% Held
Asset Management One Co., Ltd.as of 30 Jun 2025622.00k5.04%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 30 Sep 2025483.60k3.92%
Nomura Asset Management Co., Ltd.as of 08 Jan 2026358.90k2.91%
Kamakura Investment Management Co., Ltd.as of 22 Jul 2025281.60k2.28%
Amova Asset Management Co., Ltd.as of 09 Jan 2026145.60k1.18%
Dimensional Fund Advisors LPas of 08 Jan 2026143.20k1.16%
Norges Bank Investment Managementas of 30 Jun 2025126.50k1.02%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025115.60k0.94%
Sawakami Asset Management, Inc.as of 31 Oct 202560.20k0.49%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 202653.30k0.43%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.